ECONOMIC MODELING OF MEROPENEM AND CEFEPIME DOSE DE-ESCALATION BASED ON GRAM NEGATIVE SUSCEPTIBILITY

被引：0
|
作者：
Schulz, Lucas [1 ]
Rose, Warren [2 ]
Fish, Jeffrey [1 ]
机构：
[1] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
来源：
CRITICAL CARE MEDICINE | 2009年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
847
引用
收藏
页码：A414 / A414
页数：1
相关论文
共 50 条
  • [31] Brachytherapy vaginal dose de-escalation in locally advanced cervical cancer
    Mohamed, S.
    Lindegaard, J. C.
    De Leeuw, A.
    Juergenliemk-Schulz, I. M.
    Poetter, R.
    Kirisits, C.
    Tanderup, K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S101 - S101
  • [32] Management of Pediatric Nasopharyngeal Carcinoma: A Role for RT Dose De-escalation
    Wu, Cheng-Chia
    Krasin, Matthew J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (01): : 11 - 11
  • [33] Dose de-escalation to the elective nodal sites for head and neck cancer
    Nevens, D.
    Lambrecht, M.
    Duprez, G.
    Daisne, J. F.
    Van den Weyngaert, D.
    Platteaux, N.
    Geussens, Y.
    Voordeckers, M.
    De Neve, W.
    Nuyts, S.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S21 - S22
  • [34] Dose De-escalation to the Elective Lymph Nodes in Head and Neck Cancer
    Nevens, D.
    Duprez, F.
    Daisne, J. F.
    De Neve, W.
    Nuyts, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (03): : 746 - 747
  • [35] Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?
    Sanne M. Buijs
    Stijn L. W. Koolen
    Ron H. J. Mathijssen
    Agnes Jager
    Drugs, 2024, 84 : 385 - 401
  • [36] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [37] Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
    Baert, Filip
    Glorieus, Ellen
    Reenaers, Catherine
    D'Haens, Geert
    Peeters, Harald
    Franchimont, Dennis
    Dewit, Olivier
    Caenepeel, Philippe
    Louis, Edouard
    Van Assche, Gert
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (02): : 154 - 160
  • [38] Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
    Sands, Bruce E.
    Armuzzi, Alessandro
    Marshall, John K.
    Lindsay, James O.
    Sandborn, William J.
    Danese, Silvio
    Panes, Julian
    Bressler, Brian
    Colombel, Jean-Frederic
    Lawendy, Nervin
    Maller, Eric
    Zhang, Haiying
    Chan, Gary
    Salese, Leonardo
    Tsilkos, Konstantinos
    Marren, Amy
    Su, Chinyu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 271 - 280
  • [39] Susceptibility to Cefepime of Gram-negative Bacilli Isolated in a University Hospital Laboratory in Malaysia
    Ngeow, Yun Fong
    Rahman, Zainal Abidin Abd
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S75 - S75
  • [40] De-escalation of adjuvant chemotherapy for HER2 negative breast cancer
    Okines, Alicia F. C.
    Parton, Marina
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021, 11
12345